It has been shown that the upregulation of fatty acid transport proteins (FATPs) and FAT/CD36 (fatty acid translocase) that is commonly elevated in obese cases and NAFLD patients, resulted in the increased uptake of fatty acid by organs such as the skeletal and hepatic tissues (17, 18). Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.